Old Web
English
Sign In
Acemap
>
Paper
>
PRS50 Defining Type 2 Asthma and Patients Eligible to Dupilumab in Italy: A Biomarker-Based Analysis
PRS50 Defining Type 2 Asthma and Patients Eligible to Dupilumab in Italy: A Biomarker-Based Analysis
2020
G. W. Canonica
Francesco Blasi
N. Crimi
Pierluigi Paggiaro
Alberto Papi
F. Fanelli
A. Stassaldi
A. Serra
Gianluca Furneri
Keywords:
Internal medicine
Oncology
Biomarker (medicine)
Dupilumab
Asthma
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]